BRIEF-Cabaletta Bio Announces Updated Clinical Data With Rese-Cel At February Scientific Meetings

Reuters02-18

Feb 18 (Reuters) - Cabaletta Bio Inc CABA.O:

CABALETTA BIO ANNOUNCES UPDATED CLINICAL DATA DEMONSTRATING DEEPENING CLINICAL RESPONSES ACROSS MULTIPLE INDICATIONS WITH RESE-CEL AT FEBRUARY SCIENTIFIC MEETINGS

Source text: ID:nGNX4rpX96

Further company coverage: CABA.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2512515721?lang=en_US&edition=full_marsco","thumbnail":"","is_english":true,"pubTime":"2025-02-18 20:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2512515721","market":"us","top_or_hot":-1,"title":"BRIEF-Cabaletta Bio Announces Updated Clinical Data With Rese-Cel At February Scientific Meetings","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/CABA\">Cabaletta Bio</a> Announces Updated Clinical Data With Rese-Cel At February Scientific Meetings</title></head><body><p><span>Feb 18 (Reuters)</span><span> - </span>Cabaletta Bio Inc <span>CABA.O</span>:</p><ul><li><p>CABALETTA BIO ANNOUNCES UPDATED CLINICAL DATA DEMONSTRATING DEEPENING CLINICAL RESPONSES ACROSS MULTIPLE INDICATIONS WITH RESE-CEL AT FEBRUARY SCIENTIFIC MEETINGS</p></li></ul><p>Source text: <span>ID:nGNX4rpX96</span></p><p>Further company coverage: <span>CABA.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Cabaletta Bio Announces Updated Clinical Data With Rese-Cel At February Scientific Meetings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Cabaletta Bio Announces Updated Clinical Data With Rese-Cel At February Scientific Meetings\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-02-18 20:28</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/CABA\">Cabaletta Bio</a> Announces Updated Clinical Data With Rese-Cel At February Scientific Meetings</title></head><body><p><span>Feb 18 (Reuters)</span><span> - </span>Cabaletta Bio Inc <span>CABA.O</span>:</p><ul><li><p>CABALETTA BIO ANNOUNCES UPDATED CLINICAL DATA DEMONSTRATING DEEPENING CLINICAL RESPONSES ACROSS MULTIPLE INDICATIONS WITH RESE-CEL AT FEBRUARY SCIENTIFIC MEETINGS</p></li></ul><p>Source text: <span>ID:nGNX4rpX96</span></p><p>Further company coverage: <span>CABA.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CABA","symbol_name":"Cabaletta Bio","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250218:nFWN3P90DB:1","article_id":"2512515721","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2512515721","pubTimestamp":1739881694,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Cabaletta Bio Announces Updated Clinical Data With Rese-Cel At February Scientific MeetingsFeb 18 (Reuters) - Cabaletta Bio Inc CABA.O:CABALETTA BIO ANNOUNCES UPDATED CLINICAL DATA DEMONSTRATING","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CABA":"Cabaletta Bio","BK4139":"生物科技"},"translate_title":"简介-Cabaletta Bio在二月科学会议上宣布Rese-Cel的最新临床数据","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CABA":0.9},"content_text":"BRIEF-Cabaletta Bio Announces Updated Clinical Data With Rese-Cel At February Scientific MeetingsFeb 18 (Reuters) - Cabaletta Bio Inc CABA.O:CABALETTA BIO ANNOUNCES UPDATED CLINICAL DATA DEMONSTRATING DEEPENING CLINICAL RESPONSES ACROSS MULTIPLE INDICATIONS WITH RESE-CEL AT FEBRUARY SCIENTIFIC MEETINGSSource text: ID:nGNX4rpX96Further company coverage: CABA.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2512515721"}